Post job

Sienna Biopharmaceuticals CEO and executives

Executive Summary. Based on our data team's research, Frederick C Beddingfield III is the Sienna Biopharmaceuticals's CEO. Sienna Biopharmaceuticals has 58 employees, of which 12 are in a leadership position.
Here are further demographic highlights of the leadership team:
  • The Sienna Biopharmaceuticals executive team is 25% female and 75% male.
  • 56% of the management team is White.
  • 14% of Sienna Biopharmaceuticals management is Hispanic or Latino.
  • 10% of the management team is Black or African American.
Work at Sienna Biopharmaceuticals?
Share your experience

Rate Sienna Biopharmaceuticals' leaders' effectiveness in guiding the company.

Zippia waving zebra
Name & TitleBio
Frederick C Beddingfield III

CEO / President

Frederick C Beddingfield III's LinkedIn

Frederick C. Beddingfield III, MD, PhD is a physician, scientist and biotech entrepreneur and is CEO of Kira Pharmaceuticals. He is a board-certified dermatologist and emergency medicine physician fellowship trained in cutaneous surgery and oncology. Dr. Beddingfield previously served as Chief Executive Officer of Sienna Biopharmaceuticals and Chief Medical Officer of Kythera Biopharmaceuticals, Inc, which was acquired by Allergan for $2B in 2015. In addition, he was Chief Medical Officer of Allergan Medical and led the development and approval of numerous global premier drugs in over 50 countries and has led 4 successful FDA advisory committees.Dr. Beddingfield earned an MD degree with Honors from the University of North Carolina and a PhD in Policy Analysis from RAND Graduate School of Policy Studies, completing his Dermatology and Emergency Medicine residency and fellowship at UCLA in the STAR program. Currently, Dr Beddingfield is a Clinical Associate Professor of Medicine at the UCLA School of Medicine where he has been on the faculty teaching and seeing patients since 2002. He serves on the Board of Directors of several private and non-profit organizations and was the recipient of the Elle Genius Award.

Dennis M. Fenton

Board Member

Silvio Traversa

Chief Scientific Officer

Silvio Traversa is a Chief Scientific Officer at SIENNA BIOPHARMACEUTICALS, INC.. He attended Rettorato Università degli Studi di Torino.

Majed Kheir

Vice President-Operations

Sean P. Andrews

Vice President

Timothy Kirk Andrews

General Counsel

Todd Harris Ph.d

Board Member

Caroline van Hove

Chief Commercial Officer

Debra Condino

Vice President

Paul Lizzul M.d

Board Member

Do you work at Sienna Biopharmaceuticals?

Does leadership effectively guide Sienna Biopharmaceuticals toward its goals?

Sienna Biopharmaceuticals jobs

Sienna Biopharmaceuticals board members

Name & TitleBio
Frederick C Beddingfield III

CEO / President

Frederick C Beddingfield III's LinkedIn

Frederick C. Beddingfield III, MD, PhD is a physician, scientist and biotech entrepreneur and is CEO of Kira Pharmaceuticals. He is a board-certified dermatologist and emergency medicine physician fellowship trained in cutaneous surgery and oncology. Dr. Beddingfield previously served as Chief Executive Officer of Sienna Biopharmaceuticals and Chief Medical Officer of Kythera Biopharmaceuticals, Inc, which was acquired by Allergan for $2B in 2015. In addition, he was Chief Medical Officer of Allergan Medical and led the development and approval of numerous global premier drugs in over 50 countries and has led 4 successful FDA advisory committees.Dr. Beddingfield earned an MD degree with Honors from the University of North Carolina and a PhD in Policy Analysis from RAND Graduate School of Policy Studies, completing his Dermatology and Emergency Medicine residency and fellowship at UCLA in the STAR program. Currently, Dr Beddingfield is a Clinical Associate Professor of Medicine at the UCLA School of Medicine where he has been on the faculty teaching and seeing patients since 2002. He serves on the Board of Directors of several private and non-profit organizations and was the recipient of the Elle Genius Award.

Dennis M. Fenton

Board Member

Todd Harris Ph.d

Board Member

Paul Lizzul M.d

Board Member

Kristina Burow

Board Member

Sienna Biopharmaceuticals executives FAQs

Zippia gives an in-depth look into the details of Sienna Biopharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Sienna Biopharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at Sienna Biopharmaceuticals. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Sienna Biopharmaceuticals. The data presented on this page does not represent the view of Sienna Biopharmaceuticals and its employees or that of Zippia.

Sienna Biopharmaceuticals may also be known as or be related to SIENNA BIOPHARMACEUTICALS INC., Sienna Biopharmaceuticals, Sienna Biopharmaceuticals Inc and Sienna Biopharmaceuticals, Inc.